Clinical Trial Update: Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl [Phase 1]

View source ↗

Summary

This completed Phase 1 pharmacokinetic study investigates how calorie intake and fat content influence the absorption and exposure of lurasidone HCl in individu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Lurasidone HCl (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder | Phase 1 | Status: COMPLETED